Charlotte Billiet

The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy

Karin Lindberg, Vitali Grozman, Kristin Karlsson et al. · Journal of Thoracic Oncology · 2021 · 195 citations · Full text

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

R. Lieverse, Evert J. Van Limbergen, Cary Oberije et al. · BMC Cancer · 2020 · 46 citations · Full text

Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors

Sara Lindberg, Vitali Grozman, Kristin Karlsson et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 35 citations · Full text

Dose‐intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial

Matthias Gückenberger, Charlotte Billiet, Daniel Schnell et al. · Cancer · 2024 · 28 citations · Full text

Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes

Charlotte Billiet, Dirk De Ruysscher, Stéphanie Peeters et al. · Journal of Thoracic Oncology · 2016 · 25 citations · Full text

Locoregional Relapses, Radiation Therapy, Medicine +6